ADE-RED Score for Predicting ADE-Related Hospitalizations in ED Patients
This study aims to observe the frequency of hospital readmissions within 30 days due to Adverse Drug Events (ADEs) in patients who have previously visited the Emergency Department.
Data Collection
Collected from past medical records and data - RetrospectiveChemically-Induced Disorders
+ Drug-Related Side Effects and Adverse Reactions
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: November 8, 2019
Actual date on which the first participant was enrolled.Adverse drug events (ADEs) are unwanted effects caused by medications, which can sometimes lead to hospital admissions. This study focuses on a tool called ADE-RED, designed to predict the risk of hospitalization due to ADEs for patients visiting the emergency department (ED). The tool is particularly useful for identifying high-risk patients, considering factors like age, use of multiple medications, specific high-risk medications, previous ED visits, existing health conditions, and the reason for the current visit. The goal is to improve patient care and reduce the number of preventable ADE-related hospitalizations, which can cause additional harm and cost to patients. In this observational study, the ADE-RED score is used to identify patients at high risk for ADE-related hospitalizations. When a patient scores 12 or more, ED pharmacists perform a thorough review of the patient's medications and make necessary recommendations to the medical team. The primary outcome of the study is to compare the incidence of ADE-related readmissions within 30 days of a prior ED visit using the ADE-RED score, with the incidence observed in other facilities within the Methodist Health System. This comparison helps evaluate the effectiveness of the ADE-RED score in predicting and reducing ADE-related hospital readmissions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.471 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Methodist Dallas Medical Center
Dallas, United StatesOpen Methodist Dallas Medical Center in Google Maps